DRI-C21041
Product Specifications
UNSPSC Description
DRI-C21041 is a CD40/CD40L interaction inhibitor, with an IC50 of 0.31 μM. DRI-C21041 inhibits the immune response induced by alloantigen[1].
Target Antigen
TNF Receptor
Type
Reference compound
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/dri-c21041.html
Solubility
10 mM in DMSO
Smiles
O=S(C1=C2C(NC(C3=CC=C(C4=CC=C(NC(C5=CC=C([N+]([O-])=O)C=C5)=O)C=C4)C=C3)=O)=CC=CC2=CC=C1)(O)=O
Molecular Weight
567.57
References & Citations
[1]Lu H, et, al. Recent advances in the development of protein-protein interactions modulators: mechanisms and clinical trials. Signal Transduct Target Ther. 2020 Sep 23;5(1):213.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-154821/DRI-C21041-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-154821/
Clinical Information
No Development Reported
CAS Number
2101765-78-8
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
OR1023879-01 100 mg
(2S,4R) -1- (Tert-Butoxycarbonyl) -4- (Prop-2-ynyl) Pyrrolidine-2-Carboxylic Acid
Ask
View Details OR1023879-02 250 mg
(2S,4R) -1- (Tert-Butoxycarbonyl) -4- (Prop-2-ynyl) Pyrrolidine-2-Carboxylic Acid
Ask
View Details ![Rabbit Polyclonal Bad [p Ser112] Antibody](https://cdn.genprice.uk/genprice/genprice5.png)
MBS1361608-01 0.02 mg (E-Coli)
Recombinant Pseudomonas fluorescens Protein CyaY (cyaY)
Ask
View Details MBS1361608-02 0.1 mg (E-Coli)
Recombinant Pseudomonas fluorescens Protein CyaY (cyaY)
Ask
View Details